StockData
Clearmind Medicine Inc. logo

Clearmind Medicine Inc. (CMND) income statement

CMNDNasdaqPharmaceutical PreparationsFiscal year ends October 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jul 31, 2026Score 5/30
$3.06−0.39 (-11.16%)

Close on Nov 18, 2026Market cap $484.50KP/E –Yield –

Clearmind Medicine Inc. income statement

Ratios

Latest available, balances at Jul 31, 2026

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2025
–

Financial strength

Current ratio
4.31
Debt to equity
–
Debt to assets
–
Cash to current liabilities
311.9%

Valuation

P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–

See a number that looks wrong?